JPRN-UMIN000008051已完成未知
Efficacy of conbination therapy of DPP4-inhibitor and alpha-GI for type-2 diabetes patient. - Efficacy of conbination therapy of DPP4-inhibitor and alpha-GI for type-2 diabetes patient.
Third Department of Internal Medicine, Tokyo Medical University0 个研究点目标入组 5 人开始时间: 2012年5月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •contraindication for taking alogliptin contraindication for taking acarbose contraindication for taking miglitol
研究者
相似试验
已完成
不适用
Efficacy of combination therapy of DPP-4 inhibitor and alpha glucosidase inhibitor in insurin treaaed type 2 diabetes.Type 2 diabetesJPRN-UMIN000011815ational Center for Global Health and Medicine5
已完成
不适用
Effect of combination therapy with DPP-4 inhibitor and omega 3-fatty acid on glycemic control in type2 diabetes with dyslipidemiaType 2 diabetes mellitusJPRN-UMIN000010397Yokohama City University Medical Center150
已完成
不适用
The effects of the combination therapy of DPP-4 inhibitor alogliptin and alfa-glucosidase inhibitor on markers of inflammation and oxidative stress - comparison between Acarbose and Voglibosetype 2 diabetes mellitusJPRN-UMIN000007714Department of Internal Medicine, School of Medicine, Keio University40
已完成
不适用
Efficacy and safety of DPP-4 inhibitor added to insulin for treatment of type 2 diabetesType 2 diabetesJPRN-UMIN000004678Keio University , School of Mecidicine, Department of Internal Medicine50
已完成
不适用
Clinical study examining effect of DPP-4 inhibitors on postprandial hyperlipidemiaType 2 diabetes mellitusJPRN-UMIN000010177Shimane University Faculty of Medicine30